Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 7Tumor-Agnostic 2Sarcoma 1Lymphoid 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Gliosarcoma 31Glioblastoma 30Sarcoma 22Rhabdomyosarcoma 8Brain Neoplasms 7Astrocytoma 7Central Nervous System Neoplasms 6Melanoma 4Liposarcoma 4Histiocytoma, Malignant Fibrous 4Glioma 4Bone Neoplasms 4Sarcoma, Synovial 3Sarcoma, Ewing 3Rhabdomyosarcoma, Embryonal 3Osteosarcoma 3Neoplasm Metastasis 3Leiomyosarcoma 3Breast Neoplasms 3Rhabdomyosarcoma, Alveolar 2Prostatic Neoplasms 2Pain 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibrosarcoma 2Neoplasms 2Medulloblastoma 2Dermatofibrosarcoma 2Carcinoma, Merkel Cell 2Vulvar Neoplasms 1

Interventions

pembrolizumab 3talimogene laherparepvec 1spartalizumab 1daromun 1avelumab 1Therapeutics 1TTI-621 1Radiation, Ionizing 1Radiation 1Proton Pump Inhibitors 1Nivolumab 1Mohs Surgery 1Ipilimumab 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Radiation × Sarcoma × Clear all
NCT02890368 2023-04-05

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Pfizer

Phase 1 Terminated
56 enrolled
BreastDermatologicLymphoidSarcoma

Breast Neoplasms, Carcinoma, Squamous Cell, Melanoma, Mycosis Fungoides, Sarcoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡